Metabolic Reprogramming in Lung Cancer: Hallmarks, Mechanisms, and Targeted Strategies to Overcome Immune Resistance

Targeting tumor metabolic remodeling offers a promising strategy to overcome immune resistance and improve the therapeutic efficacy of immunotherapy in lung cancer. Continued efforts to elucidate the molecular mechanisms linking metabolism and immunity may pave the way for novel combination therapies with durable clinical benefits.